Navigation Links
Caris Diagnostics Announces Addition of Leading Dermatopathologist to Expand Subspecialty Expertise
Date:1/15/2008

IRVING, Texas, Jan. 15 /PRNewswire/ -- Caris Diagnostics, a leading provider of diagnostic services in anatomic pathology and molecular testing, today announced the hiring of another nationally renowned dermatopathologist for its Phoenix laboratory. Iftikhar "Ifty" Ahmed, M.D. has joined Caris Diagnostics to support the growing dermatopathology practice for the company.

"Dr. Ahmed has been a leader in the dermatopathology community for years, with his proven commitment to patient care, teaching, and research. We are pleased to add Dr. Ahmed to our growing team of high quality dermatopathologists at Caris Dx," commented Gail Marcus, President and Chief Executive Officer of Caris Diagnostics. "This outstanding addition reinforces our commitment to the highest level of subspecialty expertise as we expand the scope of our services to the healthcare community."

Dr. Ahmed joins Caris Diagnostics from the Mayo Clinic and Mayo Foundation in Rochester, MN, where he practiced for fourteen years. Most recently, he was Professor of Dermatology, Director of Dermatopathology, and Co-Director of the Dermatopathology Fellowship at the Mayo Clinic. Dr. Ahmed is board certified in Anatomic Pathology, Dermatology and Dermatopathology. He is on the editorial boards of American Journal of Dermatopathology, Dermatologic Surgery, Journal of American Academy of Dermatology, and he is Section Editor of International Journal of Dermatology. Dr. Ahmed holds the office of Vice President of the Federation for International Dermatologic Education, which provides travel and educational grants for continued education to developing countries. He has been an active lecturer at international and national meetings including the Annual Meetings of the American Society of Dermatopathology and the American Academy of Dermatology.

"The ability to attract someone of Dr. Ahmed's stature demonstrates that our goal of providing academic-caliber medicine in a commercial setting is r
'/>"/>

SOURCE Caris Diagnostics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. FDA Approves SOMA(R) (carisoprodol) 250 mg
2. Dominion Diagnostics Supports Rhode Islands Toys for Tots Initiative at Its 2007 Holiday Celebration
3. Quest Diagnostics to Speak at the Merrill Lynch Health Services Investor Conference
4. Studies Investigate Diagnostic Performance and Reproducibility of Pathwork Diagnostics Tissue of Origin Test
5. DeviceSpace Career Fair Opens Doors for Hundreds of Medical Device and Diagnostics Career Candidates
6. QED International Associates Announces Changes to the HealthShares(TM) Composite, and the HealthShares(TM) Diagnostics Indexes
7. GSW Worldwide Named Agency of Record for BioBehavioral Diagnostics Companys MMAT/ADHD(TM) System
8. Quest Diagnostics Licenses Technology Underlying SensiTrop(TM) HIV Co-Receptor Tropism Test from Pathway Diagnostics
9. ICx Technologies and Siemens Medical Solutions Diagnostics Enter In Vitro Diagnostics Development and License Option Agreement
10. Quest Diagnostics Reports Third Quarter Results
11. Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009).../ -- Physicians at Beth Israel Deaconess Medical C...y demonstrating the potential for automated analys...OR Analyzer System® to assist in rapidly ruli...ncy department (ED ) patients with chest pain. The...e of cCTA has potential to significantly reduce un...
(Date:11/30/2009)... response to a "cocaine-cues" video, active cocain...ity in brain regions linked to drug craving, accor...gy,s Brookhaven National Laboratory. The results, ...e , suggest that clinical interventions designed t... cocaine abusers stop using drugs and avoid relaps...
(Date:11/30/2009)...ore often than younger people, study finds, , ... people who are problem drinkers consume more alco...finds, possibly because they need more alcohol to ...y released this month, people dependent on alcohol... a week, on average. By contrast, younger alcoholi...
(Date:11/30/2009)...30 Baxa Corporation is sponsoring ...re of safety" means in today,s pharmacy environmen...a Culture of Safety in Pharmacy ," features a pane...experiences with culture of safety, what it takes ...ole of technology in enabling or inhibiting safe p...
(Date:11/30/2009)...swire/ -- A new study has found that 27% of Medica...ustomers have a current intention to shop for and ...re is up from 20% in 2008. Over the past four yea...eading indicator of actual switching patterns. W...tually will leave their current insurer for anothe...
Breaking Medicine News(10 mins):Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 3Health News:Brain scan study shows cocaine abusers can control cravings 2Health News:Brain scan study shows cocaine abusers can control cravings 3Health News:Binge Drinking Not Just a Rite of the Young 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3Health News:More Seniors Considering Health Insurance Switch 2
...RNewswire-FirstCall/ - IMRIS Inc. (TSX: IM) ("IMRI...iversity Huashan Hospital in Shanghai, China has s... department. Huashan Hospital will be the first in...dure without moving the patient. The project inclu...
...THAT ASTHMA PATIENTS WHO STOP USING ASTHMA CONTROL... , WASHINGTON , April 15 A new nationwide tel...ost asthma patients know the risks of "uncontrolle...s are not present. Data from The Asthma G.A.P. ...
...andards for First National Measures of Hospital Ef...art Angioplasty, and Pneumonia , , Detailed Hospi...group.org/cp , , WASHINGTON, April 15 Though it...ospitals still have failed to implement standards ...
... 15 Baptist Memorial Health Care Corp. em... phase of the "Our House is Your House" capital ca...emmons Wilson Family Center for Good Grief as they...g out to their colleagues to make donations. , , ...
...d NEW YORK, April 15 HLTH Corporation (Nasdaq: ... WebMD Health Corp. (Nasdaq: WBMD ), today annou...cial results for the three months ended March 31, ...ults. , , Investors can access the call via web...
...f endoscopic ultrasound (EUS) examination is its l... lesion. The differential diagnosis between benign...sses based on the EUS appearance is difficult and ...chnique that can be applied during ultrasound (US)...
Other Medicine News:Health News:National Survey Reveals Gap in 'Uncontrolled Asthma' Knowledge - Putting Asthma Patients at Risk for Serious Health Consequences 2Health News:National Survey Reveals Gap in 'Uncontrolled Asthma' Knowledge - Putting Asthma Patients at Risk for Serious Health Consequences 3Health News:National Survey Reveals Gap in 'Uncontrolled Asthma' Knowledge - Putting Asthma Patients at Risk for Serious Health Consequences 4Health News:Leapfrog Group Hospital Survey Finds Majority of Hospitals Fail to Meet Important Quality Standards 2Health News:Leapfrog Group Hospital Survey Finds Majority of Hospitals Fail to Meet Important Quality Standards 3Health News:Leapfrog Group Hospital Survey Finds Majority of Hospitals Fail to Meet Important Quality Standards 4Health News:Baptist Colleagues Raise $1 Million for Baptist Trinity Hospice House and Kemmons Wilson Family Center for Good Grief 2Health News:HLTH and WebMD Announce First Quarter Earnings Release Date and Conference Call 2Health News:Can EUS elastography help distinguish benign from malignant tissue? 2
(Date:11/30/2009)... Va., Nov. 30 Intelliject, Inc. to...ntis U.S. for a novel epinephrine auto-injector, i..., sanofi-aventis U.S. shall be responsible for man... be responsible for the on-going development and f...ined certain co-promotion rights in the territory....
(Date:11/30/2009)... OAKS, Calif., Nov. 30 A... will present updated long-term safety and efficac...onic immune (idiopathic) thrombocytopenic purpura ...Nplate study in a pediatric setting as well as in ...he 2009 American Society of Hematology (ASH) Annua...
(Date:11/30/2009)... November 30 , ... the European Union in,the Last 10 Years , ...announced today that the,European Commission has g...edarone - 400mg Tablets) in all 27 European member...sion positive opinion issued on September 25, 2009...
Breaking Medicine Technology:Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 2Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 3Amgen Highlights Data to be Presented at ASH 2Amgen Highlights Data to be Presented at ASH 3Amgen Highlights Data to be Presented at ASH 4Amgen Highlights Data to be Presented at ASH 5Amgen Highlights Data to be Presented at ASH 6Amgen Highlights Data to be Presented at ASH 7Amgen Highlights Data to be Presented at ASH 8Amgen Highlights Data to be Presented at ASH 9Amgen Highlights Data to be Presented at ASH 10Amgen Highlights Data to be Presented at ASH 11Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation 2Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation 3Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation 4Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation 5Insmed Announces Addition to the Russell 3000 28R 29 Index 12842 1Insmed Announces Addition to the Russell 3000 28R 29 Index 12842 2Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic CXA 101 in Patients with Complicated Urinary Tract Infections 4668 1Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic CXA 101 in Patients with Complicated Urinary Tract Infections 4668 2Growing Proteomics Market and the Current Economic Crisis Could Act in Tandem to Spur Growth in the European 2 Dimensional Gel Electrophoresis Market 50365 1Growing Proteomics Market and the Current Economic Crisis Could Act in Tandem to Spur Growth in the European 2 Dimensional Gel Electrophoresis Market 50365 2Growing Proteomics Market and the Current Economic Crisis Could Act in Tandem to Spur Growth in the European 2 Dimensional Gel Electrophoresis Market 50365 3
Hunkeler IOL Manipulator
Guimaraes ICL Manipulator
Lester IOL Manipulator
...scopes are individually adjusted for perfect focus...s, along with Keeler's wide angle light beam and i... pupil size, you will see the clearest and largest...longer life battery and fast charge capability. Wi...
Medicine Products: